Stant A D, Ten Vergert E M, den Boer P C A M, Wiersma D
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Acta Psychiatr Scand. 2008 Jan;117(1):57-66. doi: 10.1111/j.1600-0447.2007.01122.x. Epub 2007 Nov 13.
Self-therapy interventions could potentially reduce healthcare expenses and the need for care in the treatment of depression and anxiety disorders. This study assessed the cost-effectiveness of cognitive self-therapy (CST) in patients with these disorders.
A total of 151 patients were randomly assigned to CST or treatment as usual (TAU), and followed during 18 months. The Symptom Checklist 90 (SCL-90) was the primary outcome measure of the study. The reference year was 2003 (US$1.00 = euro 0.92).
Mean costs of patients in the CST group (US$4364) were lower than that of the patients who received TAU (US$5241). The results of the SCL-90 were slightly in favour of CST. Valuing an additional unit of health outcome at US$108 will lead to an 83% probability that CST is cost-effective.
Cognitive self-therapy appears to be cost-effective. Wider implementation of CST may relieve the burden of many patients with emotional disorders whose treatment needs cannot be met in current healthcare systems.
自我治疗干预措施有可能降低抑郁症和焦虑症治疗中的医疗费用及护理需求。本研究评估了认知自我治疗（CST）对这些疾病患者的成本效益。
总共151名患者被随机分配至CST组或常规治疗（TAU）组，并随访18个月。研究的主要结局指标为症状自评量表90（SCL-90）。参考年份为2003年（1.00美元 = 0.92欧元）。
CST组患者的平均费用（4364美元）低于接受TAU治疗的患者（5241美元）。SCL-90的结果略有利于CST。若将额外一个单位的健康结局价值设定为108美元，CST具有成本效益的概率将达83%。
认知自我治疗似乎具有成本效益。更广泛地实施CST可能会减轻许多情感障碍患者的负担，这些患者的治疗需求在当前医疗系统中无法得到满足。
